Morgan Stanley Maintains Overweight on Chart Industries, Raises Price Target to $200

Morgan Stanley analyst Connor Lynagh maintains Chart Industries (NYSE:GTLS) with a Overweight and raises the price target from $165 to $200.

byBenzinga Newsdesk

October 12, 2021

1 minute read

Morgan Stanley analyst Connor Lynagh maintains Chart Industries (NYSE:GTLS) with a Overweight and raises the price target from $165 to $200.

Anebulo Pharmaceuticals Q1 EPS $(0.11) Down From $(0.07) YoY

By Benzinga Newsdesk

Today, 3:22 AM

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share. This is a 57.14 percent decrease over losses of $(0.07) per share from the same period last year.

ANEB

Truist Securities Downgrades NuVasive to Hold, Announces $52.5 Price Target

By Benzinga Newsdesk

Today, 3:22 AM

Truist Securities analyst Richard Newitter downgrades NuVasive (NASDAQ:NUVA) from Buy to Hold and announces $52.5 price target.

NUVA

Tigress Financial Initiates Coverage On MultiPlan with Buy Rating, Announces Price Target of $9

By Benzinga Newsdesk

Today, 3:22 AM

Tigress Financial analyst Ivan Feinseth initiates coverage on MultiPlan (NYSE:MPLN) with a Buy rating and announces Price Target of $9.

MPLN

Tesla, Amazon, Costco, Pharvaris, Lululemon: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

Today, 3:22 AM

Major Wall Street indices closed in the green on Thursday after investors and traders questioned the possibility of continued aggression by the Federal Reserve following the release of joble

AMZN

Morgan Stanley Maintains Overweight on Chart Industries, Raises Price Target to $200

Related Posts

Anebulo Pharmaceuticals Q1 EPS $(0.11) Down From $(0.07) YoY

Truist Securities Downgrades NuVasive to Hold, Announces $52.5 Price Target

Tigress Financial Initiates Coverage On MultiPlan with Buy Rating, Announces Price Target of $9

Tesla, Amazon, Costco, Pharvaris, Lululemon: Why These 5 Stocks Are Drawing Investors’ Attention Today